Samuli Ripatti, PhD, is a Vice Director at the Institute for Molecular Medicine Finland (FIMM), a professor of Biometry at the Faculty of Medicine (UH) and a Scholar at the Broad Institute of MIT and Harvard in Cambridge, MA, USA. He is chairing the Academy of Finland Centre of Excellence in Complex Disease Genetics. His research group studies genetic variation in the Finnish population and its effects on common complex disease risks and management. His research focuses in particular on cardiometabolic diseases and cancer as models to learn about disease mechanisms and genome-based strategies for diagnosis, prevention and stratified treatment. He has played a central role in developing and testing the use of polygenic risk in prevention of cardiometabolic diseases and common cancers. He is strongly involved in doctoral training and is currently chairing Doctoral Programmes in Biomedicine and Population Health at University of Helsinki.